(Q42657184)

English

Twenty-four-month alpha-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters

scientific article published on 23 May 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 November 2017

Twenty-four-month alpha-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters (English)

1 reference

Europe PubMed Central

4 November 2017

circulatory system

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

4 November 2017

author name string

J W Koskenvuo

1

1 reference

Europe PubMed Central

4 November 2017

J J Hartiala

2

1 reference

Europe PubMed Central

4 November 2017

P Nuutila

3

1 reference

Europe PubMed Central

4 November 2017

R Kalliokoski

4

1 reference

Europe PubMed Central

4 November 2017

J S Viikari

5

1 reference

Europe PubMed Central

4 November 2017

E Engblom

6

1 reference

Europe PubMed Central

4 November 2017

M Penttinen

7

1 reference

Europe PubMed Central

4 November 2017

I Mononen

9

1 reference

Europe PubMed Central

4 November 2017

I M Kantola

10

1 reference

Europe PubMed Central

4 November 2017

publication date

23 May 2008

1 reference

Europe PubMed Central

4 November 2017

Journal of Inherited Metabolic Disease

1 reference

Europe PubMed Central

4 November 2017

31

1 reference

Europe PubMed Central

4 November 2017

3

1 reference

Europe PubMed Central

4 November 2017

432-441

1 reference

Europe PubMed Central

4 November 2017

https://scigraph.springernature.com/pub.10.1007/s10545-008-0848-3

0 references

Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study

1 reference

https://api.crossref.org/works/10.1007%2FS10545-008-0848-3

21 January 2018

Determinants of echocardiographic aortic root size. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1007%2FS10545-008-0848-3

21 January 2018

An Atypical Variant of Fabry's Disease with Manifestations Confined to the Myocardium

1 reference

https://api.crossref.org/works/10.1007%2FS10545-008-0848-3

21 January 2018

Transesophageal Echocardiography

1 reference

https://api.crossref.org/works/10.1007%2FS10545-008-0848-3

21 January 2018

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fabry disease: overall effects of agalsidase alfa treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy with agalsidase alfa in children with Fabry disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical benefit of enzyme replacement therapy in Fabry disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and Clinical Significance of Cardiac Arrhythmia in Anderson-Fabry Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New ergometric reference values for clinical exercise tests

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A practical guide to assessment of ventricular diastolic function using Doppler echocardiography

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative determination of globotriaosylceramide by immunodetection of glycolipid-bound recombinant verotoxin B subunit

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of lysosomal storage disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is left ventricular mass in apparently healthy, normotensive men correlated to maximal blood pressure during exercise?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement in serial cardiopulmonary exercise testing following enzyme replacement therapy in Fabry disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac MRI: accuracy of simultaneous measurement of left and right ventricular parameters using three different sequences

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The right ventricle in Fabry disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ambulatory blood pressure: normality and comparison with other measurements. Hypertension Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrocardiograms in Fabry's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New insights in cardiac structural changes in patients with Fabry’s disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrophysiologic findings in Fabry's disease with a short PR interval

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Echocardiographic abnormalities and disease severity in Fabry's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normal limits of the electrocardiogram in a Chinese population

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Agalsidase-beta therapy for advanced Fabry disease: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High incidence of later-onset fabry disease revealed by newborn screening

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of uncontrolled hypertension in patients with Fabry disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18509742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10545-008-0848-3

1 reference

Europe PubMed Central

4 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42657184&oldid=2085934369"